Cadrenal Therapeutics Appoints Jeff Cole as Chief Operating Officer in Advance of Tecarfarin Phase 3 Pivotal Trial
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a novel Vitamin K Antagonist (VKA) for unmet needs in anticoagulation (blood thinning) therapy, today announced the appointment of Jeff Cole to the newly created position of Chief Operating Officer. In this role, Mr….
Vivlio Health Joins athenahealth’s Marketplace Program to offer an end-to-end medical record workflow for practitioners and clinical staff
Vivlio Health, a cloud-based platform that empowers staff to simply and easily acquire medical record data from other providers, today announced an agreement with athenahealth, Inc. through the company’s Marketplace program. As part of the athenahealth® Marketplace, this newly integrated application is now…
Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum
Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative diagnostics company focused on the detection of immune responses and diagnosis of viral diseases, announced today the appointment of Dr. Nigel McCracken as the Company’s Chief Operating Officer…
